For research use only. Not for therapeutic Use.
Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.
| Catalog Number | I047476 |
| Purity | ≥95% |
| Reference | [1] Kaku S, et al. Thromb Haemost. 1996 Apr;75(4):679-84. |
